Please use this identifier to cite or link to this item: https://hdl.handle.net/2440/133826
Citations
Scopus Web of Science® Altmetric
?
?
Type: Journal article
Title: Antenatal magnesium sulphate for preventing cerebral palsy: An economic evaluation of the impact of a quality improvement program
Author: Keir, A.
Rumbold, A.
Shepherd, E.
Mcintyre, S.
Groves, C.
Cavallaro, A.
Crowther, C.
Callander, E.
Citation: Australian and New Zealand Journal of Obstetrics and Gynaecology, 2022; 62(1):168-171
Publisher: Wiley
Issue Date: 2022
ISSN: 0004-8666
1479-828X
Statement of
Responsibility: 
Amy Keir, Alice Rumbold, Emily Shepherd, Sarah Mcintyre, Charlotte Groves, Angela Cavallaro, Caroline Crowther, and Emily Callander
Abstract: Previous work demonstrated that implementing a quality improvement (QI) program improves the uptake of guideline-recommended antenatal magnesium sulphate, a critical intervention known to reduce cerebral palsy risk. Here we estimate potential cost savings attributable to the improved uptake. By expanding coverage from 63 to 83% of eligible women, we estimated that five children potentially would not have received a diagnosis of cerebral palsy, a potential cost saving of $AU4.8 million in lifetime healthcare costs. Our findings strengthen the case for embedding QI approaches in perinatal care to reduce the incidence of cerebral palsy.
Keywords: magnesium sulphate
cerebral palsy
quality improvement
cost-benefit analysis
Description: First published: 29 November 2021
Rights: © 2021 The Royal Australian and New Zealand College of Obstetricians and Gynaecologists
DOI: 10.1111/ajo.13459
Grant ID: http://purl.org/au-research/grants/nhmrc/1161379
http://purl.org/au-research/grants/nhmrc/1159536
Published version: http://dx.doi.org/10.1111/ajo.13459
Appears in Collections:Obstetrics and Gynaecology publications

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.